Dual-specificity phosphatases as targets for antineoplastic agents, Nature Reviews Drug Discovery, vol.61, issue.12, p.9612976, 2002. ,
DOI : 10.1038/nrd963
Reninsecreting tumour: about a new diagnosed case during pregnancy], Nephrol Ther, vol.1, p.52261, 2005. ,
Lipid phosphatases as drug discovery targets for type 2 diabetes, Nature Reviews Drug Discovery, vol.11, issue.4, p.3332342, 2006. ,
DOI : 10.1021/ol047316m
Protein tyrosine phosphatases: from genes, to function, to disease, Nature Reviews Molecular Cell Biology, vol.5, issue.11, p.8332846, 2006. ,
DOI : 10.1038/nrm2039
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes, Cell, vol.66, issue.4, p.8072815, 1991. ,
DOI : 10.1016/0092-8674(91)90124-H
Cantharidin-binding protein: identification as protein phosphatase 2A., Proceedings of the National Academy of Sciences, vol.89, issue.24, p.11867211870, 1992. ,
DOI : 10.1073/pnas.89.24.11867
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC50658/pdf
Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A, FEBS Letters, vol.23, issue.3, p.2832286, 1993. ,
DOI : 10.1016/0014-5793(93)80889-3
Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A, FEBS Letters, vol.376, issue.3, p.2302234, 1997. ,
DOI : 10.1016/S0014-5793(97)01210-6
Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia, Nature Medicine, vol.10, issue.6, p.7362741, 2007. ,
DOI : 10.1038/nm1588
Inhibitors of the Calcineurin / NFAT Pathway, Current Medicinal Chemistry, vol.11, issue.8, p.99721007, 2004. ,
DOI : 10.2174/0929867043455576
Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis, Embo J, vol.19, p.223722246, 2000. ,
Identification of PP1alpha as a caspase-9 regulator in IL-2 deprivation-induced apoptosis, J Immunol, vol.177, p.244122451, 2006. ,
Serine (threonine) phosphatase(s) acting on cAMP-dependent phosphoproteins in mammalian mitochondria, FEBS Letters, vol.355, issue.1-3, p.91294, 2002. ,
DOI : 10.1016/S0014-5793(02)02226-3
Site-specific and temporally-regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1, Oncogene, vol.20, issue.29, p.377623785, 2001. ,
DOI : 10.1038/sj.onc.1204518
URL : http://www.nature.com/onc/journal/v20/n29/pdf/1204518a.pdf
Protein Phosphatase Type 1-Dependent Dephosphorylation of the Retinoblastoma Tumor Suppressor Protein in Ultraviolet-Irradiated Human Skin and Keratinocytes, Journal of Investigative Dermatology, vol.115, issue.1, p.88294, 2000. ,
DOI : 10.1046/j.1523-1747.2000.00026.x
The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad, Eur J Immunol, vol.32, p.184721855, 2002. ,
Bcl-2 targets protein phosphatase 1 alpha to Bad, J Immunol, vol.166, p.734527352, 2001. ,
DOI : 10.4049/jimmunol.166.12.7345
Protein Phosphatase 2A Regulates Apoptosis in Intestinal Epithelial Cells, Journal of Biological Chemistry, vol.280, issue.35, p.31091231100, 2005. ,
DOI : 10.1074/jbc.M503041200
Inhibition of protein phosphatase 1 induces apoptosis in neonatal rat cardiac myocytes: role of adrenergic receptor stimulation, Basic Research in Cardiology, vol.95, issue.5, p.3892396, 2000. ,
DOI : 10.1007/s003950070038
Protein Phosphatase 2A Modulates the Proliferation of Human Multiple Myeloma Cells via Regulation of the Production of Reactive Oxygen Intermediates and Anti-Apoptotic Factors, Cellular Immunology, vol.213, issue.1, p.34244, 2001. ,
DOI : 10.1006/cimm.2001.1861
The toxofilin- actin-PP2C complex of Toxoplasma: identification of interacting domains, Biochem J, vol.401, p.7112719, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00478656
Anti-Cancer Therapies that Utilize Cell Penetrating Peptides, Recent Patents on Anti-Cancer Drug Discovery, vol.5, issue.2, p.992108, 2010. ,
DOI : 10.2174/157489210790936252
Use of Penetrating Peptides Interacting with PP1/PP2A Proteins As a General Approach for a Drug Phosphatase Technology, Molecular Pharmacology, vol.69, issue.4, p.111521124, 2006. ,
DOI : 10.1124/mol.105.019364
URL : https://hal.archives-ouvertes.fr/pasteur-00189544
A PKA survival pathway inhibited by DPT-PKI, a new specific cell permeable PKA inhibitor, is induced by T. annulata in parasitized B-lymphocytes, Apoptosis, vol.968, issue.23, p.126321273, 2006. ,
DOI : 10.1007/s10495-006-7702-6
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras, Cancer Res, vol.66, p.419824207, 2006. ,
A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays, Clinical Cancer Research, vol.13, issue.13, p.398923998, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-0078
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation, British Journal of Cancer, vol.65, issue.8, p.119221200, 2010. ,
DOI : 10.1038/8743
Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors, Clinical Cancer Research, vol.16, issue.8, p.235222362, 2010. ,
DOI : 10.1158/1078-0432.CCR-09-3066
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo, Molecular Cancer Therapeutics, vol.7, issue.10, p.326523274, 2008. ,
DOI : 10.1158/1535-7163.MCT-08-0268
Immunogenicity of HIV Type 1 gp120 CD4 Binding Site Phage Mimotopes, AIDS Research and Human Retroviruses, vol.21, issue.1, p.82292, 2005. ,
DOI : 10.1089/aid.2005.21.82
An engineered CX3CR1 antagonist endowed with anti-inflammatory activity, Journal of Leukocyte Biology, vol.86, issue.4, p.9032911, 2009. ,
DOI : 10.1189/jlb.0308158
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease., Molecular and Cellular Biology, vol.12, issue.3, p.9542961, 1992. ,
DOI : 10.1128/MCB.12.3.954
Phosphorylation of dis2 protein phosphatase at the C-terminal cdc2 consensus and its potential role in cell cycle regulation, Embo J, vol.13, p.531025318, 1994. ,
Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides, Molecular Cancer Therapeutics, vol.8, issue.9, p.269322707, 2009. ,
DOI : 10.1158/1535-7163.MCT-09-0228
Tumor Cell Metabolism: Cancer's Achilles' Heel, Cancer Cell, vol.13, issue.6, p.4722482, 2008. ,
DOI : 10.1016/j.ccr.2008.05.005
URL : http://doi.org/10.1016/j.ccr.2008.05.005
Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP, Clinical & Experimental Metastasis, vol.121, issue.2, 2009. ,
DOI : 10.1007/s10585-009-9237-z
Helixstabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions, Proc Natl Acad Sci, vol.100, p.11273211278, 2003. ,
DOI : 10.1073/pnas.1934759100
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC208747
Selective Inhibition of ErbB2-Overexpressing Breast Cancer In vivo by a Novel TAT-Based ErbB2-Targeting Signal Transducers and Activators of Transcription 3-Blocking Peptide, Cancer Research, vol.66, issue.7, p.376423772, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-2747
Mimicry of Protein Function with Cell-Penetrating Peptides, Methods Mol Biol, vol.683, p.2332247, 2009. ,
DOI : 10.1007/978-1-60761-919-2_17
Therapeutic applications of cellpenetrating peptides, Methods Mol Biol, vol.683, p.5352551, 2009. ,
Applications of Cell-Penetrating Peptides as Signal Transduction Modulators for the Selective Induction of Apoptosis, Methods Mol Biol, vol.683, p.2912303, 2009. ,
DOI : 10.1007/978-1-60761-919-2_21
Activation of Protein Phosphatase 1 by a Small Molecule Designed to Bind to the Enzyme's Regulatory Site, Chemistry & Biology, vol.15, issue.2, p.1672174, 2008. ,
DOI : 10.1016/j.chembiol.2008.01.005
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling, Biochemical Journal, vol.353, issue.3, p.4172439, 2001. ,
DOI : 10.1042/bj3530417
Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis, Experimental Cell Research, vol.316, issue.20, p.338723396, 2010. ,
DOI : 10.1016/j.yexcr.2010.06.007
Mammary stem cells, self-renewal pathways, and carcinogenesis, Breast Cancer Research, vol.6, issue.Suppl 1, p.86295, 2005. ,
DOI : 10.1016/j.ccr.2004.08.019
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143566
Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability, J Biol Chem, vol.280, p.29519229524, 2005. ,
DOI : 10.1074/jbc.m505317200
Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity, Oncogene, vol.7, issue.43, p.383723846, 2009. ,
DOI : 10.1158/1535-7163.MCT-08-0625
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472634
Impaired skin and mammary gland development and increased gamma-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1, Cancer Res, vol.69, p.929129300, 2009. ,
Casein Kinase I epsilon positively regulates the Akt pathway in breast cancer cell lines, Biochemical and Biophysical Research Communications, vol.368, issue.3, p.8012807, 2008. ,
DOI : 10.1016/j.bbrc.2008.02.001